DCF — THE BROOKLYN HOSPITAL CENTER
Enterprise Value: $-715.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-715.0M
Enterprise Value
$-225.1M
PV of Cash Flows
$-489.9M
PV of Terminal Value
$-789.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $415.1M | $-45.1M | -11.0% | $-62.7M | $-57.0M |
| Year 2 | $427.6M | $-42.2M | -10.0% | $-60.3M | $-49.8M |
| Year 3 | $440.4M | $-39.1M | -9.0% | $-57.7M | $-43.4M |
| Year 4 | $453.6M | $-38.0M | -8.0% | $-57.2M | $-39.1M |
| Year 5 | $467.2M | $-38.0M | -8.0% | $-57.7M | $-35.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-715.0M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$403.1M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.11372245969092717
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5